Dx & Vx Co., Ltd. (KOSDAQ:180400)
South Korea · Delayed Price · Currency is KRW 2,065.00
-10.00 (-0.48%)
At close: Nov 13, 2026
Dx & Vx Market Cap
Dx & Vx has a market cap or net worth of 203.26 billion as of November 13, 2026. It is the 22,180th most valuable company in the world and the 792nd biggest in South Korea. Its market cap has increased by 100.47% in one year.
Market Cap
203.26B
Enterprise Value
169.43B
Revenue
26.22B
Global Rank
Country Rank
#792 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 20, 2015, Dx & Vx's market cap has increased from 75.32B to 203.26B, an increase of 169.87%. That is a compound annual growth rate of 9.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 203.26B | 31.52% |
| Dec 30, 2025 | 154.55B | 68.91% |
| Dec 30, 2024 | 91.50B | -48.77% |
| Dec 28, 2023 | 178.59B | 52.96% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 211.30B |
| GC Medical Science | 69.37B |
| Inventera | 60.57B |
| Cytogen | 53.65B |
| GENINUS | 53.53B |
| Protia | 53.23B |
| HLB Panagene | 48.17B |
| Seoulin Bioscience | 29.06B |